Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SULT1A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IFT20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NTN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAGE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRP8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNRNP40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01088 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SULT1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MORN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD19B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on